Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes

Diabetic Medicine

Volumn 28, Issue 10, 2011, Pages 1188-1193

  Matheus, A S De M ^a   Tibirica E ^a,b   Da Silva, P B ^a   De Fatima Bevilacqua da Matta M ^a   Gomes, M B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Endothelium; Type 1 diabetes mellitus; Uric acid

Indexed keywords

ACETYLCHOLINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE DURATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPEREMIA; INSULIN DEPENDENT DIABETES MELLITUS; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR ENDOTHELIAL CELL; PATHOGENESIS;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; URIC ACID; YOUNG ADULT;

EID: 80053034933     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03349.x     Document Type: Article

References (28)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. N Engl J Med 1993; 329: 977-986.
2. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR. Mortality from heart disease in a cohort of 23000 patients with insulin-treated diabetes. Diabetologia 2003; 46: 760-765.
3. Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type1 diabetes. Diabetes Care 2006; 29: 1860-1865.
4. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26: 1374-1379.
5. Gomes MB, Cobas RA, Nunes E, Castro-Faria-Neto HC, da Matta MF, Neves R et al. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type1 diabetes mellitus. Diabetes Res Clin Pract 2009; 85: 61-68.
6. Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D. Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type1 diabetes. Diabetes Care 2007; 30: 649-654.
7. Gomes M B, Matheus ASM, Tibiriçá E. Evaluation of microvascular endothelial function in patients with type1 diabetes using laser-Doppler perfusion monitoring: which method to choose? Microvasc Res 2008; 76: 132-133.
8. Franklin VL, Khan F, Kennedy G, Belch JJF, Greene SA. Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type1 diabetes. Diabetologia 2008; 51: 353-360.
9. Tibiriçá E, Rodrigues E, Cobas RA, Gomes MB. Endothelial function in patients with type1 diabetes evaluated by skin capillary recruitment. Microvasc Res 2007; 73: 107-112.
10. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in non-proteinuric patients with type1 diabetes. Clin J Am Nephrol 2008; 3: 706-713.
11. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
12. Zoppini G, Targher G, Negri C, Stoico V, Perrone F, Muggeo M et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type2 diabetic patients. Diabetes Care 2009; 32: 1716-1720.
13. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005; 25: 39-42.
14. Waring WS, McKnight JA, Webb DJ, Maxwell SRJ. Uric acid restores endothelial function in patients with type1 diabetes and regular smokers. Diabetes 2006; 55: 3127-3132.
15. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS et al. Nitrosative stress, uric acid, and peripheral nerve function in early type1 diabetes. Diabetes 2002; 51: 2817-2825.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 14: 499-502.
17. Cracowski JL, Christopher TM, Salvat-Mellis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006; 27: 503-508.
18. Koitka A, Abraham P, Bouhanick B, Roussel DS, Demiot C, Saumet JL. Impaired pressure-induced vasodilation at the foot in young adults with type1 diabetes. Diabetes 2005; 53: 721-725.
19. Chan NN, Vallance P, Colhoun HM. Endothelium-dependent and independent vascular dysfunction in type1 diabetes: role of conventional risk factors, sex, and glycemic control. Arterioscler Thromb Vasc Biol 2003; 23: 1048-1054.
20. Cosentino F, Eto M, De Paolis P, Van der Loo B, Bachschmid M, Ullrich V et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells role of protein kinaseC and reactive oxygen species. Circulation 2003; 107: 1017-1023.
21. Browne D, Meeking D, Shaw K, Cummings M. Endothelial dysfunction and pre-symptomatic atherosclerois in type1 diabetes-pathogenesis and identification. Br J Diabetes Vasc Dis 2003; 3: 27-34.
22. Gołembiewska E, Ciechanowski K, Safranow K, Kedzierska K, Kabat-Koperska J. Renal handling of uric acid in patients with type1 diabetes in relation to glycemic control. Arch Med Res 2005; 36: 32-35.
23. Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type2 diabetes mellitus: the urate redox shuttle. Nutr Metab 2004; 19: 1-10.
24. Renard CB, Kramer F, Johansson F, Lamharz N, Tannock LR, von Herrath MG et al. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 2004; 114: 659-668.
25. Kim SW, Kim SC, Nam KC, Kang ES, Im JJ, Kim DW. A new method of screening for diabetic neuropathy using laser Doppler and photoplethysmography. Med Biol Eng Comp 2008; 46: 61-67.
26. Kubli S, Waeber B, Dalle-Ave A, Feihl F. Reproducibility of laser-Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiol Pharm 2000; 36: 640-648.
27. Tibiriçá E, Matheus ASM, Nunes B, Sperandei S, Gomes MB. Repeatability of the evaluation of systemic microvascular endothelial function using laser Doppler perfusion monitoring: clinical and statistical implications. Clinics 2011; 66: 1-6.
28. Debbabi H, Bonnin P, Ducluzeau PH, Lefthériotis G, Levy BI. Non-invasive assessment of endothelial function in the skin microcirculation. Am J Hypertens 2010; 23: 541-546.